PT141
Research Compound · 1 vial x 10mg
$37
| Pack size | 1 vial x 10mg |
| Also known as | Bremelanotide |
| Compound type | Cyclic heptapeptide; MC3/MC4 receptor agonist |
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Molecular formula | C50H68N14O10 |
| Molecular weight | 1025.2 g/mol |
| CAS number | 189691-06-3 |
| Form | Lyophilized powder |
| Purity | 99% Pure |
| Storage | Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol. |
| Intended use | Laboratory research only |
This product is sold exclusively for laboratory research use by qualified professionals and institutions. It is not a drug, food, cosmetic, or dietary supplement, and is not approved for use in humans or animals. Handling must be performed only by trained personnel in a controlled research setting.
Research overview
PT-141 (bremelanotide) is a cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone that acts mainly on the MC3 and MC4 melanocortin receptors. It is a likely metabolite of melanotan II, differing by a C-terminal acid in place of an amide, and was approved in the United States in 2019.
Research areas
- MC4 receptor pharmacology
- Central melanocortin signaling
- Neuroendocrine research
Sources
Handling and storage
Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol.